Allianz Nudges Its Record High as Buybacks and a Fortified Balance Sheet Do the Heavy Lifting
Published on 08/11/2026 at 17:21 | Redaktion boerse-global.de
The insurance giant is once again knocking on the door of its 52-week peak, and this time it brings a thicker capital cushion and a shrinking share count to the conversation. Allianz closed Tuesday at €436.10, a modest 0.46% dip, leaving the stock just 1.74% shy of its €443.80 ceiling. The proximity to that watermark has investors weighing whether the operational momentum that powered the recent run still has enough fuel for a breakout — or whether the chart is flashing an overbought warning.
A Quarter of Records, With One Blip in the Fine Print
The numbers out of Munich this week were hard to fault at first glance. Operating profit for the second quarter rose 11% to €4.9 billion, a figure that dovetails with a first-half tally of €9.4 billion, up 8.6% year on year. Management reaffirmed its full-year target of €17.4 billion in operating earnings, with a corridor of plus or minus €1 billion — a range that, on current trajectory, looks comfortably attainable.
The standout performer was asset management. Net inflows hit a record €84 billion in the first half, lifting assets under management to €2.161 trillion. That engine room is doing much of the heavy lifting for group growth, and it also happens to be the segment most exposed to market volatility. Whether those inflows can persist if conditions turn choppier is arguably the single biggest swing factor for the equity story.
Not everything sparkled. The value of new business in the life/health division slipped 8.1% to €2.355 billion in the first half — a soft patch that bears watching even as the property-casualty unit delivered a combined ratio of 91.4%, better than the 92%–93% target band.
Buybacks and a Bulwark of Capital
The share repurchase program remains a central pillar of the bull case. Between August 3 and 7, Allianz bought back 218,432 of its own shares at prices ranging from €433.53 to €441.86 — a signal that the board sees value even within striking distance of the record. Of the current program, which runs to €2.5 billion, roughly €1.4 billion has already been deployed, with completion expected in the fourth quarter of 2026.
Backing that shareholder-friendly posture is a balance sheet that keeps getting stronger. The Solvency II ratio climbed seven percentage points to 225%, an unusually robust buffer for an insurer of this scale. That firepower gives management room to keep buying stock while also absorbing any operational surprises.
The market's arithmetic already reflects much of this strength. At a market capitalization of €167.15 billion, the shares trade 13.48% above their 200-day moving average and have gained 11.68% since the start of the year. Over twelve months, the advance is a more substantial 20.49%.
The Technical Crossroads
The bulls can point to a double floor of support: the 50-day moving average at €412.76 and the 200-day line well below that. As long as the former holds, the constructive chart setup remains intact. A decisive breach of €443.80, on the other hand, could open the path toward the €486 price target set by DZ Bank in a recent upgrade.
When evaluating risk, the same discipline that guides investment decisions applies to workplace safety — and many employers overlook a critical gap in their compliance documentation. A free toolkit with 41 ready-to-use templates and checklists helps you document risks properly and protect your business. Download the free Risk Assessment Toolkit
The bears, however, have their own technical argument. The relative strength index sits at 63.8 on the primary data and 67.3 on the secondary reading — both approaching, though not yet inside, the overbought zone above 70. After a rally of this magnitude, profit-taking at the record high would hardly be a surprise. If the stock fails at resistance, the next downside reference would be the 100-day average at €394.40, with a break of the 50-day line serving as the first formal warning of a broader correction.
What Happens Next
The coming weeks will test whether Allianz can convert operational strength into a sustainable breakout. The upper end of the guidance range — €18.4 billion on the primary measure — remains within reach, but only if claims development and the interest rate environment cooperate. The buyback cadence will also bear watching; each weekly update on repurchase volume offers a fresh read on how much conviction management holds at these levels.
For now, the setup is genuinely two-sided. The fundamentals are strong enough to justify the valuation, yet the technicals suggest the easy gains have been banked. The resolution likely hinges on whether asset management can sustain its record inflow pace and whether the life/health weakness proves a temporary blemish rather than the start of a trend. Until one of those questions answers itself, the stock looks destined to consolidate just beneath its ceiling — with the €443.80 mark serving as the line between continuation and correction.
